| Heather Stallings, APRN | |
|
1021 Neil Dr, Jonesboro, AR 72401-4462 | |
| (870) 898-0088 | |
| Not Available |
| Full Name | Heather Stallings |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 1021 Neil Dr, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013359769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A003923 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wound Solutions Of Central Arkansas Llc | 7911365028 | 8 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
| Entity Name | Healwell Of Northeast Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932817806 PECOS PAC ID: 9830568120 Enrollment ID: O20221208000674 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
| Entity Name | Wound Solutions Of Central Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447952346 PECOS PAC ID: 7911365028 Enrollment ID: O20230622000972 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
| Entity Name | Wound Solutions Of Nwa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043904261 PECOS PAC ID: 7517321466 Enrollment ID: O20230912001308 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
| Entity Name | Wound Solutions Of Nea Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386337665 PECOS PAC ID: 9335597681 Enrollment ID: O20231127001730 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Stallings, APRN 1021 Neil Dr, Jonesboro, AR 72401-4462 Ph: () - | Heather Stallings, APRN 1021 Neil Dr, Jonesboro, AR 72401-4462 Ph: (870) 898-0088 |
News Archive
For only the second time in its near 80-year history, the American Geriatrics Society will award one of its highest honors typically reserved for individuals to West Health, a family of nonprofit organizations dedicated to lowering healthcare costs to enable older adults to successfully age in place.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.
A typical visit to the pediatrician when it is time for a child to get a shot can include tears, tantrums and might not seem worth the trouble.
Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.
› Verified 8 days ago
Mrs. Renata Jane Vaughn, APN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1530 N Church St, Jonesboro, AR 72401 Phone: 870-802-3590 Fax: 870-327-7970 | |
Sandra Troxel, DNP/APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2816 Fox Meadow Ln, Jonesboro, AR 72404 Phone: 870-336-1675 | |
Jesse Ash, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 225 E Jackson Ave, Jonesboro, AR 72401 Phone: 870-207-4100 | |
Ms. Amy Mary Elizabeth Daughhetee, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 225 East Washington Ave, Jonesboro, AR 72401 Phone: 870-207-4100 | |
Candice Brianne Burnside, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 225 E Jackson Ave, Jonesboro, AR 72401 Phone: 870-207-1630 | |
Katie J Hutton, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-910-7726 |